Myotonic dystrophy type 1 (DM1), the commonest type of muscular dystrophy in adults, is caused by expansion of CTG repeats in the 3′UTR of the DMPK gene. Sequestration of the alternative splicing regulator MBNL1 (muscleblind-like protein 1) by CUG expansions in DMPK transcripts is associated with some of the pathogenic features of DM1. Llamusi et al. now identify two RNA-binding proteins, BSF and TBPH, as modifiers of CTG toxicity in a Drosophila model of DM1. They report that these proteins and Muscleblind (the fly orthologue of MBNL1) are present in the sarcomeres of normal flight muscle, and that CTG expansion disrupts this expression pattern. Importantly, TBPH silencing improves the dystrophic muscle phenotype. These results provide new clues about DM1 and identify TBPH as a potential therapeutic target. Page 184
Myotonic dystrophy: new clues from flies
- Split-screen
- Views Icon Views
-
Article Versions Icon
Versions
- Version of Record 01 January 2013
- Share Icon Share
-
Tools Icon
Tools
- Search Site
Myotonic dystrophy: new clues from flies. Dis Model Mech 1 January 2013; 6 (1): 1. doi:
Download citation file:
Advertisement
Cited by
Special Issue: The RAS Pathway

Our latest special issue is now complete. It showcases RAS-driven mechanisms of disease progression, and highlights approaches to treat and modify the disease course in model systems.
Call for papers: Moving Heart Failure to Heart Success

Disease Models & Mechanisms is pleased to welcome submissions for consideration for an upcoming special issue, Moving Heart Failure to Heart Success: Mechanisms, Regeneration & Therapy. The deadline for submitting articles to the special issue has been extended to 1 August 2022.
Propose a new Workshop

Our Workshops bring together leading experts and early-career researchers from a range of scientific backgrounds. Applications are now open to propose Workshops for 2024, one of which will be held in a Global South country. .
A focus on Drosophila

In a series of front section articles, DMM is highlighting the versatility, breadth, and scope of Drosophila research in human disease modelling and translational medicine.
Apply for a DMM Conference Travel Grant

Aimed at early-career researchers wanting to attend in-person and virtual meetings, the next application deadline for a DMM Conference Travel Grant is 6 June 2022. Find out more and hear from past recipients about their experience of the grant.
Other journals from
The Company of Biologists